The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Noriyuki Takai

Department of Obstetrics and Gynecology

Oita University Faculty of Medicine

Yufu-shi

Oita 879-5593

Japan

[email]@med.oita-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Yufu-shi, Oita 879-5593, Japan. 2004 - 2010

References

  1. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Int. J. Mol. Med. (2010) [Pubmed]
  2. Anti-neoplastic effect of β-hydroxyisovalerylshikonin on a human choriocarcinoma cell line. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Mol. Med. Report (2010) [Pubmed]
  3. Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Mol. Med. Report (2010) [Pubmed]
  4. Lymphoepithelioma-like carcinoma of the uterine cervix. Takai, N., Nakamura, S., Goto, K., Hayashita, C., Kira, N., Urabe, S., Narahara, H., Matsumoto, H. Arch. Gynecol. Obstet. (2009) [Pubmed]
  5. Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas. Takai, N., Ueda, T., Nasu, K., Yamashita, S., Toyofuku, M., Narahara, H. Cancer Lett. (2009) [Pubmed]
  6. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Int. J. Mol. Med. (2008) [Pubmed]
  7. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Oncol. Rep. (2008) [Pubmed]
  8. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Int. J. Mol. Med. (2008) [Pubmed]
  9. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Gynecol. Oncol. (2008) [Pubmed]
  10. Bowel obstruction due to endometriosis in the rectovaginal septum. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Clin. Exp. Obstet. Gynecol (2008) [Pubmed]
  11. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis. Takai, N., Narahara, H. Curr. Med. Chem. (2007) [Pubmed]
  12. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Gynecol. Oncol. (2006) [Pubmed]
  13. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Int. J. Mol. Med. (2006) [Pubmed]
  14. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Matsuda, K., Kusumoto, M., Narahara, H. Oncology (2006) [Pubmed]
  15. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells. Takai, N., Ueda, T., Nishida, M., Nasu, K., Narahara, H. Anticancer Res. (2006) [Pubmed]
  16. Polo-like kinases (Plks) and cancer. Takai, N., Hamanaka, R., Yoshimatsu, J., Miyakawa, I. Oncogene (2005) [Pubmed]
  17. Management of patients with carcinoma of the cervix with anuric renal failure. Takai, N., Nasu, K., Miyakawa, I. Int. J. Gynaecol. Obstet (2005) [Pubmed]
  18. Placenta percreta invading the urinary bladder. Takai, N., Eto, M., Sato, F., Mimata, H., Miyakawa, I. Arch. Gynecol. Obstet. (2005) [Pubmed]
  19. K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1. Takai, N., Ueda, T., Nishida, M., Nasu, K., Fukuda, J., Miyakawa, I. Oncol. Rep. (2005) [Pubmed]
  20. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma. Takai, N., Ueda, T., Kawano, Y., Nishida, M., Nasu, K., Narahara, H. Oncol. Rep. (2005) [Pubmed]
  21. The relationship between oncogene expression and clinical outcome in endometrial carcinoma. Takai, N., Ueda, T., Nishida, M., Nasu, K., Miyakawa, I. Curr. Cancer. Drug. Targets (2004) [Pubmed]
 
WikiGenes - Universities